IPP Bureau
PromoCell launches custom GMP cell culture media to power next-gen cell and gene therapies
By IPP Bureau - October 07, 2025
New offering to debut at the 32nd ESGCT Congress, October 7–10, 2025, in Seville, Spain
IMCD unveils future of beauty at In-Cosmetics Latin America 2025
By IPP Bureau - October 07, 2025
IMCD engaged with manufacturers, formulators, and brand leaders, offering valuable insights into evolving consumer trends
Molcure and Boehringer Ingelheim team up to supercharge antibody discovery with AI
By IPP Bureau - October 07, 2025
This collaboration aims to combine Molcure’s cutting-edge AI technology with Boehringer Ingelheim’s extensive expertise in drug discovery
Lonza expands cell and gene therapy portfolio
By IPP Bureau - October 07, 2025
Lonza boosts TheraPEAK line with new Cytokines and AAV Medium for next-gen therapies
Health Secretary Srivastava chairs meeting with states/UTs on quality and rational use of cough syrups
By IPP Bureau - October 06, 2025
States exhorted to ensure rational use of cough syrups, particularly among children, as most coughs are self-limiting and do not require pharmacological treatment
FDA supports new ANDA prioritization pilot to support US generic drugs
By IPP Bureau - October 06, 2025
AGC Pharma Chemicals opens new €100 million manufacturing plant in Spain
By IPP Bureau - October 06, 2025
It represents a 30% increase in the company’s production capacity and introduces a segment dedicated to highly potent active ingredients
India invites applications under PRIP scheme to drive pharma-medtech innovation
By IPP Bureau - October 06, 2025
Early stage projects of up to Rs. 9 crore eligible for up to Rs. 5 crore assistance and later stage projects of up to Rs. 285 crore eligible for up to Rs. 100 crore assistance
Lilly to invest $1 billion+ in new contract manufacturing in India
By IPP Bureau - October 06, 2025
Investment to expand manufacturing and global medicine supply capacity
Roche’s AI-based kidney disease algorithm gains European certification
By IPP Bureau - October 06, 2025
The new algorithm will be introduced as part of Roche’s CKD Algorithm Panelon thenavify Algorithm Suite
TAHO Pharma submits NDA to FDA for world’s first Apixaban oral dissolving film
By IPP Bureau - October 06, 2025
Pioneering innovation aims to transform anticoagulant therapy and improve patient outcomes
Evofem's SOLOSEC submitted for regulatory approval in the UAE
By IPP Bureau - October 06, 2025
Marks first international filing for Evofem’s single-dose oral treatment
Nanavati Max, Uzbekistan’s NVRH forge alliance to advance healthcare and training
By IPP Bureau - October 06, 2025
Wockhardt submits NDA to USFDA for Zidebactam-Cefepime injection
By IPP Bureau - October 05, 2025
The NDA submission follows the successful completion of a pivotal Phase III global clinical trial
